Centene stock holds near health insurance peers after latest earnings

Centene Corp. (US15133V1035) remains a closely watched managed-care name after its latest reported quarter showed $41.4 billion in premium and service revenue in Q1 2026, adjusted diluted EPS of $2.90, and 28.3 million total members as of 31 March 2026. Those figures frame Centene stock against a business mix that is still dominated by government-sponsored health plans.

Q1 2026 sets the base

Centene reported premium and service revenue of $41.4 billion in Q1 2026, compared with the same quarter a year earlier, while adjusted diluted EPS came in at $2.90 for the period ended 31 March 2026. The member base reached 28.3 million, a scale figure that matters because enrollment trends feed directly into premium revenue and utilization.

The quarter also gives the stock a clear numerical anchor: earnings power and membership are both visible, and both are current enough to matter for the next read-through. For investors, the combination of revenue scale and per-share profitability is more useful than broad sector commentary.

Revenue and earnings compare

Centene's premium and service revenue of $41.4 billion in Q1 2026 provides the first key comparison point, while adjusted diluted EPS of $2.90 offers the second. The company also said total members were 28.3 million at the end of the quarter, which is a concrete operating measure rather than a generic business description.

That mix is important because managed-care stocks often move on the spread between premium growth, medical cost trends, and earnings conversion. A quarter with $41.4 billion in revenue and $2.90 in adjusted EPS gives Centene a harder-to-ignore fundamental baseline than a narrative alone would.

Membership remains the swing factor

Centene's 28.3 million total members as of 31 March 2026 show how large the operating platform remains, especially in government programs. The same quarter's revenue and EPS figures suggest that the business is still converting scale into earnings, even as the market keeps a close eye on utilization and reimbursement patterns.

The stock case therefore rests on whether those quarterly numbers can hold up in the next reporting cycle. A stable or rising membership base usually matters because it supports premium revenue, while any pressure on earnings conversion can quickly change how the market values the shares.

Centene stock and Molina

Centene's product mix is centered on Medicaid, Medicare and marketplace health plans, with the Medicaid segment still a core driver of membership and premium revenue. The latest quarter's 28.3 million members show why that exposure remains central to the investment debate.

Among peers, managed-care investors often compare Centene with other large US health insurers on revenue scale, earnings quality and government-program exposure. Centene stock is now easier to read because Q1 2026 supplied three hard numbers in one report: $41.4 billion of revenue, $2.90 of adjusted EPS and 28.3 million members.

Price and market value

Centene shares trade on the NYSE in USD, and the stock's market reading is best interpreted alongside the latest reported operating figures rather than in isolation. The article's central facts are the Q1 2026 revenue, adjusted EPS and member base, which give the shares a measurable valuation backdrop.